Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA, Olszewski AJ.
Curr Treat Options Oncol. 2018 Jun 21;19(8):38. doi: 10.1007/s11864-018-0555-8.
Diffuse large B-cell lymphoma variants: an update.
Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ.
Pathology. 2020 Jan;52(1):53-67. doi: 10.1016/j.pathol.2019.08.013. Epub 2019 Nov 15.
How we treat primary central nervous system lymphoma.
Calimeri T, Steffanoni S, Gagliardi F, Chiara A, Ferreri AJM.
ESMO Open. 2021 Aug;6(4):100213. doi: 10.1016/j.esmoop.2021.100213. Epub 2021 Jul 13.
Primary large B-cell lymphomas of immune-privileged sites.
Roschewski M, Phelan JD, Jaffe ES.
Blood. 2024 Dec 19;144(25):2593-2603. doi: 10.1182/blood.2023020911.
The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J, Ishaque N, Koll R, Gu Z, Schumann E, Sieverling L, Uhrig S, Hübschmann D, Toprak UH, López C, Hostench XP, Borgoni S, Juraeva D, Pritsch F, Paramasivam N, Balasubramanian GP, Schlesner M, Sahay S, Weniger M, Pehl D, Radbruch H, Osterloh A, Korfel A, Misch M, Onken J, Faust K, Vajkoczy P, Moskopp D, Wang Y, Jödicke A, Trümper L, Anagnostopoulos I, Lenze D, Küppers R, Hummel M, Schmitt CA, Wiestler OD, Wolf S, Unterberg A, Eils R, Herold-Mende C, Brors B; ICGC MMML-Seq Consortium; Siebert R, Wiemann S, Heppner FL.
Nat Commun. 2022 May 10;13(1):2558. doi: 10.1038/s41467-022-30050-y.
Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.
T Low J, B Peters K.
CNS Oncol. 2020 Mar 1;9(1):CNS51. doi: 10.2217/cns-2019-0022. Epub 2020 Mar 6.
MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial.
Ferreri AJM, Doorduijn JK, Re A, Cabras MG, Smith J, Ilariucci F, Luppi M, Calimeri T, Cattaneo C, Khwaja J, Botto B, Cellini C, Nassi L, Linton K, McKay P, Olivieri J, Patti C, Re F, Fanni A, Singh V, Bromberg JEC, Cozens K, Gastaldi E, Bernardi M, Cascavilla N, Davies A, Fox CP, Frezzato M, Osborne W, Liberati AM, Novak U, Zambello R, Zucca E, Cwynarski K; International Extranodal Lymphoma Study Group (IELSG).
Lancet Haematol. 2021 Feb;8(2):e110-e121. doi: 10.1016/S2352-3026(20)30366-5.
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C, Morandi L, Righi S, Cirillo L, Iommi M, Tonon C, Mazzatenta D, Zoli M, Rossi M, Bagnato G, Broccoli A, Lodi R, Zinzani PL, Sabattini E, Giannini C, Asioli S.
Mod Pathol. 2023 Dec;36(12):100323. doi: 10.1016/j.modpat.2023.100323. Epub 2023 Sep 9.
Central nervous system prophylaxis in diffuse large B-cell lymphoma.
Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK.
Eur J Haematol. 2016 Aug;97(2):108-20. doi: 10.1111/ejh.12763. Epub 2016 May 25.
Primary central nervous system CD20-negative diffuse large B-cell lymphoma: a case report.
Luo S, Huang X, Li Y, Wang J.
BMC Neurol. 2022 Dec 29;22(1):504. doi: 10.1186/s12883-022-03031-3.
